555 related articles for article (PubMed ID: 26347749)
1. Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives.
Pawig L; Klasen C; Weber C; Bernhagen J; Noels H
Front Immunol; 2015; 6():429. PubMed ID: 26347749
[TBL] [Abstract][Full Text] [Related]
2. The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease.
Döring Y; Pawig L; Weber C; Noels H
Front Physiol; 2014; 5():212. PubMed ID: 24966838
[TBL] [Abstract][Full Text] [Related]
3. Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3.
Gao X; Abdelkarim H; Albee LJ; Volkman BF; Gaponenko V; Majetschak M
PLoS One; 2018; 13(9):e0204041. PubMed ID: 30248140
[TBL] [Abstract][Full Text] [Related]
4. MIF interacts with CXCR7 to promote receptor internalization, ERK1/2 and ZAP-70 signaling, and lymphocyte chemotaxis.
Alampour-Rajabi S; El Bounkari O; Rot A; Müller-Newen G; Bachelerie F; Gawaz M; Weber C; Schober A; Bernhagen J
FASEB J; 2015 Nov; 29(11):4497-511. PubMed ID: 26139098
[TBL] [Abstract][Full Text] [Related]
5. Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.
Benredjem B; Girard M; Rhainds D; St-Onge G; Heveker N
J Biol Chem; 2017 Jan; 292(1):31-42. PubMed ID: 27875312
[TBL] [Abstract][Full Text] [Related]
6. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
Khare T; Bissonnette M; Khare S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
[TBL] [Abstract][Full Text] [Related]
7. Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function.
Cheng YH; Eby JM; LaPorte HM; Volkman BF; Majetschak M
PLoS One; 2017; 12(11):e0187949. PubMed ID: 29125867
[TBL] [Abstract][Full Text] [Related]
8. Functions of the CXCL12 Receptor ACKR3/CXCR7-What Has Been Perceived and What Has Been Overlooked.
Koch C; Engele J
Mol Pharmacol; 2020 Nov; 98(5):577-585. PubMed ID: 32883765
[TBL] [Abstract][Full Text] [Related]
9. Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis.
Tillmann S; Bernhagen J; Noels H
Front Immunol; 2013; 4():115. PubMed ID: 23720662
[TBL] [Abstract][Full Text] [Related]
10. Macrophage Migration Inhibitory Factor-CXCR4 Receptor Interactions: EVIDENCE FOR PARTIAL ALLOSTERIC AGONISM IN COMPARISON WITH CXCL12 CHEMOKINE.
Rajasekaran D; Gröning S; Schmitz C; Zierow S; Drucker N; Bakou M; Kohl K; Mertens A; Lue H; Weber C; Xiao A; Luker G; Kapurniotu A; Lolis E; Bernhagen J
J Biol Chem; 2016 Jul; 291(30):15881-95. PubMed ID: 27226569
[TBL] [Abstract][Full Text] [Related]
11. Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function.
Bach HH; Wong YM; Tripathi A; Nevins AM; Gamelli RL; Volkman BF; Byron KL; Majetschak M
Mol Med; 2014 Oct; 20(1):435-47. PubMed ID: 25032954
[TBL] [Abstract][Full Text] [Related]
12. MIF and CXCL12 in Cardiovascular Diseases: Functional Differences and Similarities.
van der Vorst EP; Döring Y; Weber C
Front Immunol; 2015; 6():373. PubMed ID: 26257740
[TBL] [Abstract][Full Text] [Related]
13. Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.
Jaracz-Ros A; Bernadat G; Cutolo P; Gallego C; Gustavsson M; Cecon E; Baleux F; Kufareva I; Handel TM; Bachelerie F; Levoye A
J Leukoc Biol; 2020 Jun; 107(6):1123-1135. PubMed ID: 32374043
[TBL] [Abstract][Full Text] [Related]
14. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands.
Zabel BA; Wang Y; Lewén S; Berahovich RD; Penfold ME; Zhang P; Powers J; Summers BC; Miao Z; Zhao B; Jalili A; Janowska-Wieczorek A; Jaen JC; Schall TJ
J Immunol; 2009 Sep; 183(5):3204-11. PubMed ID: 19641136
[TBL] [Abstract][Full Text] [Related]
15. Identification of an Arg-Leu-Arg tripeptide that contributes to the binding interface between the cytokine MIF and the chemokine receptor CXCR4.
Lacy M; Kontos C; Brandhofer M; Hille K; Gröning S; Sinitski D; Bourilhon P; Rosenberg E; Krammer C; Thavayogarajah T; Pantouris G; Bakou M; Weber C; Lolis E; Bernhagen J; Kapurniotu A
Sci Rep; 2018 Mar; 8(1):5171. PubMed ID: 29581527
[TBL] [Abstract][Full Text] [Related]
16. CXCR7 Mediates Neural Progenitor Cells Migration to CXCL12 Independent of CXCR4.
Chen Q; Zhang M; Li Y; Xu D; Wang Y; Song A; Zhu B; Huang Y; Zheng JC
Stem Cells; 2015 Aug; 33(8):2574-85. PubMed ID: 25833331
[TBL] [Abstract][Full Text] [Related]
17. Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7.
Szpakowska M; Dupuis N; Baragli A; Counson M; Hanson J; Piette J; Chevigné A
Biochem Pharmacol; 2016 Aug; 114():14-21. PubMed ID: 27238288
[TBL] [Abstract][Full Text] [Related]
18. ACKR3 Regulation of Neuronal Migration Requires ACKR3 Phosphorylation, but Not β-Arrestin.
Saaber F; Schütz D; Miess E; Abe P; Desikan S; Ashok Kumar P; Balk S; Huang K; Beaulieu JM; Schulz S; Stumm R
Cell Rep; 2019 Feb; 26(6):1473-1488.e9. PubMed ID: 30726732
[TBL] [Abstract][Full Text] [Related]
19. Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting.
Kontos C; El Bounkari O; Krammer C; Sinitski D; Hille K; Zan C; Yan G; Wang S; Gao Y; Brandhofer M; Megens RTA; Hoffmann A; Pauli J; Asare Y; Gerra S; Bourilhon P; Leng L; Eckstein HH; Kempf WE; Pelisek J; Gokce O; Maegdefessel L; Bucala R; Dichgans M; Weber C; Kapurniotu A; Bernhagen J
Nat Commun; 2020 Nov; 11(1):5981. PubMed ID: 33239628
[TBL] [Abstract][Full Text] [Related]
20. The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases.
García-Cuesta EM; Santiago CA; Vallejo-Díaz J; Juarranz Y; Rodríguez-Frade JM; Mellado M
Front Endocrinol (Lausanne); 2019; 10():585. PubMed ID: 31507535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
